应用免疫组化的方法,检测T和辅助T(Th)淋巴细胞在52例肾透明细胞癌中的表达,进行分析、研究与预后的关系。结果:T—LI≥10％组生存率明显高于T—LI<10％组(P<0.05);Th—LI≥10％、Th—LI<10％两组间生存率无明显差异(P>0.05),T—LI、Th—LI与肿瘤分期,核分级无相关性。结论:T—LI可以作为肾透明细胞癌的预后指标;Th—LI与预后无相关性。 Immunohistochemical method was used to detect the expression of T and helper T (Th) lymphocytes in 52 cases of renal clear cell carcinoma, and to analyze the relationship between prognosis and T lymphocytes. Results: The survival rates in T-LI≥10% group were significantly higher than those in T-LI <10% group (P <0.05). There was no significant difference in survival rate between Th-LI≥10% and Th-LI <10% > 0.05), T-LI, Th-LI and tumor stage, nuclear grade no correlation. Conclusion: T-LI can be used as a prognostic indicator of renal clear cell carcinoma; Th-LI has no correlation with prognosis.